An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease - Wikidata - awgldk - TriplyDB

An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease

An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease

http://www.wikidata.org/entity/Q36650399

about

Montreal Cognitive Assessment for the diagnosis of Alzheimer’s disease and other dementias Brain investigation and brain conceptualization Untangling tau imaging Magnetic Resonance Imaging to Detect Early Molecular and Cellular Changes in Alzheimer's Disease A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers Candidate mechanisms underlying the association between sleep-wake disruptions and Alzheimer's disease Suspected non-Alzheimer disease pathophysiology--concept and controversy Overestimating the Effects of Healthy Aging The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015 Fractional anisotropy of the fornix and hippocampal atrophy in Alzheimer's disease The relevance of beta-amyloid on markers of Alzheimer's disease in clinically normal individuals and factors that influence these associations Advances in Alzheimer's disease drug development Testing the right target and right drug at the right stage Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals Harmonized diagnostic criteria for Alzheimer's disease: recommendations Ushering in the study and treatment of preclinical Alzheimer disease Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation Imago Mundi, Imago AD, Imago ADNI Thinner temporal and parietal cortex is related to incident clinical progression to dementia in patients with subjective cognitive decline Amyloid, neurodegeneration, and small vessel disease as predictors of dementia in the oldest-old.Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2 The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement.Recent Progress in Alzheimer's Disease Research, Part 3: Diagnosis and Treatment.Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition.Diabetes and elevated hemoglobin A1c levels are associated with brain hypometabolism but not amyloid accumulation.Rates of β-amyloid accumulation are independent of hippocampal neurodegeneration.Amyloid burden and neural function in people at risk for Alzheimer's Disease.Neuroprotective pathways: lifestyle activity, brain pathology, and cognition in cognitively normal older adults.18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.Is verbal episodic memory in elderly with amyloid deposits preserved through altered neuronal function?Biological heterogeneity in ADNI amnestic mild cognitive impairment.Smoking and increased Alzheimer's disease risk: a review of potential mechanisms The effects of aging and Alzheimer's disease on cerebral cortical anatomy: specificity and differential relationships with cognition Association of hypometabolism and amyloid levels in aging, normal subjects Vascular risk and Aβ interact to reduce cortical thickness in AD vulnerable brain regions.Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates.Self-reported memory complaints: implications from a longitudinal cohort with autopsies.Cognitive profile of amyloid burden and white matter hyperintensities in cognitively normal older adults.Operationalizing hippocampal volume as an enrichment biomarker for amnestic mild cognitive impairment trials: effect of algorithm, test-retest variability, and cut point on trial cost, duration, and sample size.Primary age-related tauopathy (PART): a common pathology associated with human aging

P2860

Q24186280-B1FFD9E1-C889-4C67-8023-B5FE1D848BCC Q24604341-8EE4058F-8DD7-4E73-B80A-87B303408270 Q26739091-CDFF6CCF-F549-4D71-B6C1-947EA2847142 Q26744646-4307E935-708C-40E9-A1EB-E43D3A41B10B Q26745508-93FC92A0-09AF-414C-82CD-BD14E03DE248 Q26753192-B3E2995C-1FC0-4FF4-9D7C-5336D95063B0 Q26771270-462E9316-FBFE-4F5E-B89B-E671A80664DF Q26785333-58B1B25D-3A50-40CE-8A0C-7037186443D7 Q26801654-678C68E2-212A-4C83-A68C-8636A5D5CA00 Q26827268-5BAC84C3-11C4-4290-880C-C39340D8CFF0 Q26830467-21D4C0AC-6994-4CD3-98EF-B147E8E9778D Q26849352-94260033-5A85-489C-9EB8-335B73D5580F Q26864854-DE0F4E1E-C095-4E0E-8BF2-1ADA11E5CE36 Q26995405-79EB0C9B-0A69-4281-80DA-D1C010E5BF47 Q27009157-CD551B5B-6282-416E-B4A8-3D7A3F97D158 Q27014791-D516BF19-EF7F-486F-9B46-486DCE7A6E21 Q27303745-215D815F-AAFD-477B-AA00-ACFB6CD476D6 Q28650395-826127EF-E339-4492-8913-EA410CBB666B Q30239789-9B5EABB1-5F84-4BAB-B836-8887E692FA09 Q30303122-14C18F80-2539-4CAF-BD9E-76FD8C628EA5 Q30981669-7A21D877-317D-4253-A08A-90FA742B46DA Q31147579-F6DF8162-03A4-4722-BD0A-7ED5FEB0348F Q33556068-B73DBDDB-133F-4658-80D1-A3C8C269D6E5 Q33559175-3D088B5F-19DC-4934-BEEE-76C00216841C Q33573761-FB0C6D1F-3D51-4C9E-80CD-D2E881551823 Q33581412-2E40D15E-4D15-47ED-90F9-16A6A4913A1E Q33599047-1BE5A51C-6E5D-47B9-AB0D-F25DDC681262 Q33605578-25F94826-0667-45CD-B6C5-288B6834E817 Q33740879-33362256-F7B7-45F1-84ED-CD23F0AC0A41 Q33872248-940BBABB-EE2F-4C5F-A9C3-622C754017AC Q33882478-91F8E32A-742E-4FF5-8F89-943EE161347D Q33902721-4F6C58EE-BE90-4DFC-95AD-249769E75B9C Q33902744-FEFDC984-DD0C-4D33-B24D-C2A8D57183E7 Q33927230-29C63C87-69BF-46B1-997D-F31C6945B10E Q33965410-49C2732B-BB70-4F99-BA9C-57D16CBCEC37 Q34047002-6BF32365-17D5-4DBD-8BE8-238060E27317 Q34303840-F106925E-0BB4-4AFE-815A-6E3EFD63B133 Q34311853-0D76E928-F2DA-4A7E-AEF6-C21EB6DEBF38 Q34364619-2E61D326-14C0-4BD0-983E-6A7DD7E4732C Q34445021-650B301A-1A68-4E8E-8852-5431C860AE48

P2860

An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease

http://www.wikidata.org/entity/Q36650399

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

An operational approach to Nat ...... preclinical Alzheimer disease

@ast

An operational approach to Nat ...... preclinical Alzheimer disease

@en

type

label

An operational approach to Nat ...... preclinical Alzheimer disease

@ast

An operational approach to Nat ...... preclinical Alzheimer disease

@en

prefLabel

An operational approach to Nat ...... preclinical Alzheimer disease

@ast

An operational approach to Nat ...... preclinical Alzheimer disease

@en

P1433

Q36650399-F320564D-0F8C-45DD-8BC3-B20B467F63E3

P1476

Q36650399-B3CE4A5D-B295-46BC-9E36-52E5519136E4

P2093

Q36650399-26B9A73F-D17A-4FD7-9234-2A2214E840A1

Q36650399-4170518E-303D-4F1F-8DFF-0E8586A06D71

Q36650399-4B9D4F3A-24E0-4B4D-B8FA-B0CC37E39907

Q36650399-51705BF2-3112-4935-88D1-EEAB373C1127

Q36650399-5265CEE7-46F5-42E7-883D-8BF3DEAAF0A3

Q36650399-647FA975-F2BF-403B-B947-41061BE7632E

Q36650399-7E0160A4-0223-4A3C-86A7-2F1F261F4BE4

Q36650399-EB8DC509-45A7-40A3-AAE6-4EB1F201AB38

Q36650399-FE56A70D-6091-49FA-909D-E3E279F75CF9

P2860

Q36650399-0CB8916D-6C8E-4E67-9643-8EDB35DF86C4

Q36650399-1265181C-61D3-4803-802E-6274C77AD4DA

Q36650399-1622B384-CE45-444B-951C-EB39D9242C3B

Q36650399-1ADEA33C-3E83-41C9-812C-43EDD2F6F9A2

Q36650399-1B88E452-3000-49DD-A398-BB1191652F0B

Q36650399-1C939305-DAD9-4183-89A9-2BC1EFFF15F7

Q36650399-20CFEAB4-3ECC-4AA5-BF0D-658F1A4D01A8

Q36650399-21B5276D-B163-4240-9AB5-65A6895AB0A1

Q36650399-225D1950-D2C8-43EE-9E74-37E064BF9BEF

Q36650399-25B600A3-2FFA-42AB-990F-340DF89AC989

P304

Q36650399-F9FACBD0-519C-4797-915E-F9AD8BFA6E86

P31

Q36650399-D8EC2656-5748-42B7-8A94-EC64703DBC8B

P356

Q36650399-1135B0DB-E6FA-4C02-BAE3-8D1B97A2DD42

P407

Q36650399-4F7CF172-217D-4432-B491-2B2CD321894D

P433

Q36650399-912DC77E-3B1E-469B-8B2E-2B4627BFB99D

P478

Q36650399-BFCE0A9E-1F48-4B9F-8827-F60BA43DDCEB

P50

Q36650399-5657C24A-B2A8-402D-A291-E33C2B2E0A4D

Q36650399-718E6AF8-867D-4A0B-916F-E3E8F5A2C2D4

Q36650399-79F05262-235E-4734-BC27-FEC0EAA111CB

Q36650399-95C8257A-73FA-4E6A-B1B3-87C6EA7E8F2D

Q36650399-F567F5F2-F878-4BED-9EB2-EB13A2BD5B34

P577

Q36650399-DDCBB973-355A-4B30-A53A-A27D518BF6E7

P698

Q36650399-35749F3D-D576-4D4D-9F9E-680CF2BAED86

P921

Q36650399-C3395243-C125-4016-9FF1-E2218E40E5DF

P932

Q36650399-40CC7BFF-BDCA-4DB4-8350-79BDA4A8F4BE

P356

P1433

Annals of Neurology

P1476

An operational approach to Nat ...... preclinical Alzheimer disease

@en

P2093

Bradley F Boeve

http://www.w3.org/2001/XMLSchema#string

Heather J Wiste

http://www.w3.org/2001/XMLSchema#string

Jeffrey L Gunter

http://www.w3.org/2001/XMLSchema#string

Prashanthi Vemuri

http://www.w3.org/2001/XMLSchema#string

Robert J Ivnik

http://www.w3.org/2001/XMLSchema#string

Rosebud O Roberts

http://www.w3.org/2001/XMLSchema#string

Stephen D Weigand

http://www.w3.org/2001/XMLSchema#string

Val Lowe

http://www.w3.org/2001/XMLSchema#string

Walter A Rocca

http://www.w3.org/2001/XMLSchema#string

P2860

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain

Alzheimer's disease diagnosis in individual subjects using structural MR images: validation studies

Antemortem MRI based STructural Abnormality iNDex (STAND)-scores correlate with postmortem Braak neurofibrillary tangle stage.

Measurement of MRI scanner performance with the ADNI phantom.

Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease

Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative.

P304

765-775

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.22628

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P50

Matthew L Senjem

Ronald C. Petersen

David S Knopman

P577

2012-04-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22488240

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3586223

http://www.w3.org/2001/XMLSchema#string